Low expression of ITGα3 significantly improved the prognosis of pancreatic cancer patients compared with high expression of ITGα3 according to independent PACA-AU, PAAD-US-TCGA, GSE79688, GSE62452, GSE57495, and GSE17891 datasets. Here, ITGA3 is linked to pancreatic neoplasm.